DigestRedComo funciona
Red
/
Empresas
Sc
No verificado

Scribe Therapeutics Inc.

Sobre qué escribimos

BiotecnologíaCardiologíaEventosFarmacéuticaSalud

12 Comunicados de prensa

Ver todos los comunicados de prensa
17/11/2025
Ciencia
Biotecnología
Medicina - Varios
Cardiología
Salud
Farmacéutica
Eventos
Ferias y Congresos
Industria
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
09/09/2025
Cardiología
Biotecnología
Técnica
Salud
Farmacéutica
Ciencia
Medicina - Varios
Eventos
Industria
Scribe Therapeutics Highlights Latest Data on Lp(a)-Lowering Therapy and Novel AI Platform for Next-Generation CRISPR-Based Therapeutics at Two Premier Conferences
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
22/05/2025
Eventos
Industria
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
05/05/2025
Industria
Biotecnología
Salud
Farmacéutica
Scribe Therapeutics to Highlight In Vivo CRISPR-based Genome Editing Data for Duchenne Muscular Dystrophy at ASGCT 2025, in Addition to Joint Presentation with Prevail Therapeutics, a Part of Lilly’s Gene Therapy Division
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
23/04/2025
Eventos
Industria
Salud
Biotecnología
Sanidad
Farmacéutica
Cardiología
Scribe Therapeutics to Unveil Latest Preclinical Data on Proprietary CRISPR Epigenetic Silencing Technology for LDL-C Lowering at the 2025 EAS Congress
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
07/03/2025
Eventos
Industria
Biotecnología
Salud
Cardiología
Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
26/02/2025
Ciencia
Biotecnología
Farmacéutica
Salud
Sanidad
Eventos
Scribe Therapeutics to Participate in Upcoming Conferences
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
13/01/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Medicina - Varios
Cardiología
Salud
Farmacéutica
Oncología
Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
09/01/2025
Finanzas
Eventos
Ferias y Congresos
Salud
Biotecnología
Sanidad
Farmacéutica
Scribe Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0
25/11/2024
Eventos
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Cardiología
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
Fuente
Scribe Therapeutics Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0